Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.15)
# 1,387
Out of 4,412 analysts
100
Total ratings
41.84%
Success rate
-7.8%
Average return
Main Sectors:
Top Industries:
16 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics | Maintains: Buy | $54 → $2 | $21.03 | -90.49% | 5 | Apr 23, 2024 | |
| LEGN Legend Biotech | Reiterates: Buy | $87 | $45.30 | +92.05% | 18 | Apr 23, 2024 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $50 | $38.57 | +29.63% | 10 | Apr 17, 2024 | |
| CARM Carisma Therapeutics | Maintains: Buy | $11 → $9 | $1.64 | +448.78% | 6 | Apr 2, 2024 | |
| KRRO Korro Bio | Maintains: Buy | $100 → $115 | $62.93 | +82.74% | 3 | Mar 28, 2024 | |
| TIL Instil Bio | Reiterates: Buy | $18 | $10.60 | +69.81% | 5 | Mar 25, 2024 | |
| RANI Rani Therapeutics Holdings | Maintains: Buy | $16 → $12 | $6.68 | +79.64% | 9 | Mar 25, 2024 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $19 → $23 | $15.67 | +46.78% | 9 | Mar 20, 2024 | |
| NGNE Neurogene | Maintains: Buy | $45 → $55 | $29.96 | +83.58% | 4 | Mar 19, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $13 | $2.88 | +351.39% | 10 | Mar 15, 2024 | |
| RLYB Rallybio | Maintains: Buy | $12 → $9 | $1.70 | +429.41% | 8 | Mar 13, 2024 | |
| LYEL Lyell Immunopharma | Maintains: Buy | $8 → $6 | $2.17 | +176.50% | 5 | Feb 29, 2024 | |
| RPHM Reneo Pharmaceuticals | Downgrades: Neutral | $30 → $1.5 | $1.67 | -10.18% | 3 | Dec 15, 2023 | |
| ADTX Aditxt | Maintains: Buy | $4 → $61 | $2.39 | +2,452.30% | 2 | Sep 6, 2023 | |
| TCBP TC Biopharm (Holdings) | Maintains: Buy | $1,800 → $1,400 | $1.53 | +91,403.27% | 2 | Apr 27, 2023 | |
| CTMX CytomX Therapeutics | Downgrades: Neutral | n/a | $1.59 | - | 1 | Jul 11, 2022 |
Cartesian Therapeutics
Apr 23, 2024
Maintains: Buy
Price Target: $54 → $2
Current: $21.03
Upside: -90.49%
Legend Biotech
Apr 23, 2024
Reiterates: Buy
Price Target: $87
Current: $45.30
Upside: +92.05%
Halozyme Therapeutics
Apr 17, 2024
Reiterates: Buy
Price Target: $50
Current: $38.57
Upside: +29.63%
Carisma Therapeutics
Apr 2, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.64
Upside: +448.78%
Korro Bio
Mar 28, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $62.93
Upside: +82.74%
Instil Bio
Mar 25, 2024
Reiterates: Buy
Price Target: $18
Current: $10.60
Upside: +69.81%
Rani Therapeutics Holdings
Mar 25, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $6.68
Upside: +79.64%
Tyra Biosciences
Mar 20, 2024
Reiterates: Buy
Price Target: $19 → $23
Current: $15.67
Upside: +46.78%
Neurogene
Mar 19, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $29.96
Upside: +83.58%
Century Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $13
Current: $2.88
Upside: +351.39%
Rallybio
Mar 13, 2024
Maintains: Buy
Price Target: $12 → $9
Current: $1.70
Upside: +429.41%
Lyell Immunopharma
Feb 29, 2024
Maintains: Buy
Price Target: $8 → $6
Current: $2.17
Upside: +176.50%
Reneo Pharmaceuticals
Dec 15, 2023
Downgrades: Neutral
Price Target: $30 → $1.5
Current: $1.67
Upside: -10.18%
Aditxt
Sep 6, 2023
Maintains: Buy
Price Target: $4 → $61
Current: $2.39
Upside: +2,452.30%
TC Biopharm (Holdings)
Apr 27, 2023
Maintains: Buy
Price Target: $1,800 → $1,400
Current: $1.53
Upside: +91,403.27%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.59
Upside: -